Related Articles
p53 autoantibodies in the sera, cyst and ascitic fluids of patients with ovarian cancer.
E-cadherin immunoreactivity correlates with recurrence and progression of minimally invasive transitional cell carcinomas of the urinary bladder
Relationship between p53 gene mutation and protein expression: clinical significance in transitional cell carcinoma of the bladder.
High-throughput tissue microarray analysis of COX2 expression in urinary bladder cancer
CHROMOSOMAL MARKERS AS PROGNOSTIC INDICATORS IN TRANSITIONAL-CELL CARCINOMAS OF THE BLADDER